Considering that the inhibitory effects of GRIM-19 on STAT3 activation may be tumor or cell type-dependent [20], we investigated whether disturbed STAT3 is involved in GRIM-19 loss-driven GC tumorigenesis in GC. The gene discussed is NDUFA13; the disease is gastric cancer.